NEOGEN CORP (NEOG) Fundamental Analysis & Valuation
NASDAQ:NEOG • US6404911066
Current stock price
9.24 USD
-0.18 (-1.91%)
At close:
9.24 USD
0 (0%)
After Hours:
This NEOG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NEOG Profitability Analysis
1.1 Basic Checks
- NEOG had positive earnings in the past year.
- In the past year NEOG had a positive cash flow from operations.
- In multiple years NEOG reported negative net income over the last 5 years.
- Each year in the past 5 years NEOG had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -18.12%, NEOG perfoms like the industry average, outperforming 50.53% of the companies in the same industry.
- NEOG has a Return On Equity of -28.96%. This is comparable to the rest of the industry: NEOG outperforms 54.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.12% | ||
| ROE | -28.96% | ||
| ROIC | N/A |
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- NEOG's Gross Margin of 45.20% is on the low side compared to the rest of the industry. NEOG is outperformed by 61.17% of its industry peers.
- In the last couple of years the Gross Margin of NEOG has remained more or less at the same level.
- The Profit Margin and Operating Margin are not available for NEOG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
2. NEOG Health Analysis
2.1 Basic Checks
- NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NEOG has about the same amount of shares outstanding.
- The number of shares outstanding for NEOG has been increased compared to 5 years ago.
- The debt/assets ratio for NEOG is higher compared to a year ago.
2.2 Solvency
- NEOG has an Altman-Z score of 1.14. This is a bad value and indicates that NEOG is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of NEOG (1.14) is comparable to the rest of the industry.
- NEOG has a debt to FCF ratio of 129.92. This is a negative value and a sign of low solvency as NEOG would need 129.92 years to pay back of all of its debts.
- NEOG has a better Debt to FCF ratio (129.92) than 64.89% of its industry peers.
- A Debt/Equity ratio of 0.38 indicates that NEOG is not too dependend on debt financing.
- NEOG has a Debt to Equity ratio (0.38) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 129.92 | ||
| Altman-Z | 1.14 |
ROIC/WACCN/A
WACC8.04%
2.3 Liquidity
- NEOG has a Current Ratio of 3.92. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.
- NEOG has a Current ratio of 3.92. This is in the better half of the industry: NEOG outperforms 62.77% of its industry peers.
- A Quick Ratio of 2.84 indicates that NEOG has no problem at all paying its short term obligations.
- The Quick ratio of NEOG (2.84) is better than 60.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.92 | ||
| Quick Ratio | 2.84 |
3. NEOG Growth Analysis
3.1 Past
- NEOG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.32%.
- The earnings per share for NEOG have been decreasing by -10.20% on average. This is quite bad
- NEOG shows a decrease in Revenue. In the last year, the revenue decreased by -3.91%.
- NEOG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.43% yearly.
EPS 1Y (TTM)-26.32%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-10%
Revenue 1Y (TTM)-3.91%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-4.43%
3.2 Future
- The Earnings Per Share is expected to grow by 7.29% on average over the next years.
- The Revenue is expected to decrease by -0.50% on average over the next years.
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue Next Year-3.76%
Revenue Next 2Y-2.53%
Revenue Next 3Y-2.01%
Revenue Next 5Y-0.5%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. NEOG Valuation Analysis
4.1 Price/Earnings Ratio
- NEOG is valuated quite expensively with a Price/Earnings ratio of 33.00.
- Based on the Price/Earnings ratio, NEOG is valued a bit cheaper than 70.74% of the companies in the same industry.
- When comparing the Price/Earnings ratio of NEOG to the average of the S&P500 Index (27.38), we can say NEOG is valued slightly more expensively.
- Based on the Price/Forward Earnings ratio of 27.24, the valuation of NEOG can be described as expensive.
- Based on the Price/Forward Earnings ratio, NEOG is valued a bit cheaper than the industry average as 73.94% of the companies are valued more expensively.
- NEOG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33 | ||
| Fwd PE | 27.24 |
4.2 Price Multiples
- 68.09% of the companies in the same industry are more expensive than NEOG, based on the Enterprise Value to EBITDA ratio.
- 65.43% of the companies in the same industry are more expensive than NEOG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 329.39 | ||
| EV/EBITDA | 33.91 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.38%
EPS Next 3Y9.52%
5. NEOG Dividend Analysis
5.1 Amount
- No dividends for NEOG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NEOG Fundamentals: All Metrics, Ratios and Statistics
9.24
-0.18 (-1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-09 2026-04-09/bmo
Earnings (Next)07-27 2026-07-27/amc
Inst Owners104.08%
Inst Owner Change0.01%
Ins Owners0.65%
Ins Owner Change22.13%
Market Cap2.01B
Revenue(TTM)870.54M
Net Income(TTM)-608.78M
Analysts78.18
Price Target11.48 (24.24%)
Short Float %4.67%
Short Ratio3.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.85%
Min EPS beat(2)53.45%
Max EPS beat(2)78.25%
EPS beat(4)3
Avg EPS beat(4)48.29%
Min EPS beat(4)-34.64%
Max EPS beat(4)96.08%
EPS beat(8)4
Avg EPS beat(8)19.98%
EPS beat(12)5
Avg EPS beat(12)49.94%
EPS beat(16)7
Avg EPS beat(16)44.82%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)1.26%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)1.83%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)5.99%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)5
Avg Revenue beat(12)0.05%
Revenue beat(16)5
Avg Revenue beat(16)-0.5%
PT rev (1m)0%
PT rev (3m)44.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.69%
EPS NY rev (1m)0%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33 | ||
| Fwd PE | 27.24 | ||
| P/S | 2.31 | ||
| P/FCF | 329.39 | ||
| P/OCF | 28.92 | ||
| P/B | 0.96 | ||
| P/tB | N/A | ||
| EV/EBITDA | 33.91 |
EPS(TTM)0.28
EY3.03%
EPS(NY)0.34
Fwd EY3.67%
FCF(TTM)0.03
FCFY0.3%
OCF(TTM)0.32
OCFY3.46%
SpS4
BVpS9.66
TBVpS-1.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.80061 (-15.58%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.12% | ||
| ROE | -28.96% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.2% | ||
| FCFM | 0.7% |
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
F-Score4
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 129.92 | ||
| Debt/EBITDA | 10.02 | ||
| Cap/Depr | 54.14% | ||
| Cap/Sales | 7.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 87.87% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.92 | ||
| Quick Ratio | 2.84 | ||
| Altman-Z | 1.14 |
F-Score4
WACC8.04%
ROIC/WACCN/A
Cap/Depr(3y)85.8%
Cap/Depr(5y)97.5%
Cap/Sales(3y)10.58%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.32%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-10%
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue 1Y (TTM)-3.91%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-4.43%
Revenue Next Year-3.76%
Revenue Next 2Y-2.53%
Revenue Next 3Y-2.01%
Revenue Next 5Y-0.5%
EBIT growth 1Y-254.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.34%
EBIT Next 3Y34.61%
EBIT Next 5Y20.01%
FCF growth 1Y146.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.1%
OCF growth 3Y-5.05%
OCF growth 5Y-7.47%
NEOGEN CORP / NEOG Fundamental Analysis FAQ
What is the fundamental rating for NEOG stock?
ChartMill assigns a fundamental rating of 3 / 10 to NEOG.
What is the valuation status of NEOGEN CORP (NEOG) stock?
ChartMill assigns a valuation rating of 3 / 10 to NEOGEN CORP (NEOG). This can be considered as Overvalued.
Can you provide the profitability details for NEOGEN CORP?
NEOGEN CORP (NEOG) has a profitability rating of 2 / 10.
How financially healthy is NEOGEN CORP?
The financial health rating of NEOGEN CORP (NEOG) is 5 / 10.
Can you provide the expected EPS growth for NEOG stock?
The Earnings per Share (EPS) of NEOGEN CORP (NEOG) is expected to decline by -9.33% in the next year.